Important message regarding the discontinuation of Namenda® (memantine HCl) tablets: The general sale and distribution of Namenda tablets will be discontinued [date]. The oral solution of Namenda will continue to be broadly available, along with once-daily NAMENDA XR® (memantine HCl) extended release capsules.
[NAMENDA tablets will be available exclusively from Foundation Care, based on physician’s indication of medical need for twice-daily tablet formulation. Patients and Caregivers: Please talk to your healthcare provider to see if Namenda XR is an option for you or your loved one. HCPs: For patients who you determine have medical need for twice daily NAMENDA tablets, Foundation Care Pharmacy is the exclusive distributor. Please click here to download the form below and fax it to 1-844-572-0970 to request NAMENDA tablets for your patient. ]
Dosing and side effects information
Most common side effects of NAMENDA
If the person you are caring for has just started or is about to start taking NAMENDA (memantine HCl), you may be wondering about the possibility of side effects.
NAMENDA may cause side effects in some patients. In clinical trials, the most common side effects occurring in at least 2% of patients treated with NAMENDA and at a greater rate than patients given placebo (sugar pill) are listed here (see chart below). Dizziness, confusion, headache, and constipation occurred at a rate of at least 5% in NAMENDA-treated patients and at a greater rate than in the placebo group.
Adverse events reported in ≥2% of patients receiving NAMENDA and
at a higher frequency than in placebo-treated patients
|Most Common Side Effects||NAMENDA||Placebo (sugar pill)|
For a complete list of side effects associated with NAMENDA treatment, please see the full Prescribing Information.
There is no evidence that NAMENDA prevents or slows the underlying disease process in patients with Alzheimer's disease.
IMPORTANT RISK INFORMATION FOR NAMENDA
Who should NOT take NAMENDA?
NAMENDA should not be taken by anyone who is allergic (hypersensitive) to memantine, the active substance in NAMENDA, or who has had a bad reaction to NAMENDA or any of its ingredients.
What should be discussed with the healthcare provider before taking NAMENDA?
Before starting NAMENDA, talk to the healthcare provider about all of the patient's past and present medical conditions, including:
- Seizure disorders
- Difficulty passing urine
- Liver, kidney or bladder problems
If the patient is taking other medications (including those without a prescription), ask the healthcare provider if NAMENDA is right for the patient.
- Certain medications, changes in diet, or medical conditions may affect the amount of NAMENDA in the body and possibly increase side effects.
What are the possible side effects of NAMENDA?
The most common side effects associated with NAMENDA treatment are dizziness, confusion, headache, and constipation. This is not a complete list of side effects.
Please see full Prescribing Information.